Article ; Online: Pyrrolidine dithiocarbamate reduces alloxan-induced kidney damage by decreasing nox4, inducible nitric oxide synthase, and metalloproteinase-2.
Naunyn-Schmiedeberg's archives of pharmacology
2020 Volume 393, Issue 10, Page(s) 1899–1910
Abstract: We examined the effect of the NFκB inhibitor pyrrolidine-1-carbodithioic acid (PDTC) on inducible nitric oxide synthase (iNOS), matrix metalloproteinase-2 (MMP-2) activity, and oxidative and inflammatory kidney damage in alloxan-induced diabetes. Two ... ...
Abstract | We examined the effect of the NFκB inhibitor pyrrolidine-1-carbodithioic acid (PDTC) on inducible nitric oxide synthase (iNOS), matrix metalloproteinase-2 (MMP-2) activity, and oxidative and inflammatory kidney damage in alloxan-induced diabetes. Two weeks after diabetes induction (alloxan-130 mg/kg), control and diabetic rats received PDTC (100 mg/kg) or vehicle for 8 weeks. Body weight, glycemia, urea, and creatinine were measured. Kidney changes were measured in hematoxylin/eosin sections and ED1 by immunohistochemistry. Kidney thiobarbituric acid reactive substances (TBARS), superoxide anion (O2-), and nitrate/nitrite (NOx) levels, and catalase and superoxide dismutase (SOD) activities were analyzed. Also, kidney nox4 and iNOS expression, and NFkB nuclear translocation were measured by western blot, and MMP-2 by zymography. Glycemia and urea increased in alloxan rats, which were not modified by PDTC treatment. However, PDTC attenuated kidney structural alterations and macrophage infiltration in diabetic rats. While diabetes increased both TBARS and O |
---|---|
MeSH term(s) | Alloxan/toxicity ; Animals ; Antioxidants/pharmacology ; Antioxidants/therapeutic use ; Kidney Diseases/chemically induced ; Kidney Diseases/drug therapy ; Kidney Diseases/enzymology ; Male ; Matrix Metalloproteinase 2/metabolism ; Matrix Metalloproteinase Inhibitors/pharmacology ; Matrix Metalloproteinase Inhibitors/therapeutic use ; NADPH Oxidase 4/antagonists & inhibitors ; NADPH Oxidase 4/metabolism ; Nitric Oxide Synthase Type II/antagonists & inhibitors ; Nitric Oxide Synthase Type II/metabolism ; Pyrrolidines/pharmacology ; Pyrrolidines/therapeutic use ; Rats ; Rats, Wistar ; Thiocarbamates/pharmacology ; Thiocarbamates/therapeutic use |
Chemical Substances | Antioxidants ; Matrix Metalloproteinase Inhibitors ; Pyrrolidines ; Thiocarbamates ; pyrrolidine dithiocarbamic acid (25769-03-3) ; Alloxan (6SW5YHA5NG) ; Nitric Oxide Synthase Type II (EC 1.14.13.39) ; Nos2 protein, rat (EC 1.14.13.39) ; NADPH Oxidase 4 (EC 1.6.3.-) ; Nox4 protein, rat (EC 1.6.3.-) ; Matrix Metalloproteinase 2 (EC 3.4.24.24) ; Mmp2 protein, rat (EC 3.4.24.24) |
Language | English |
Publishing date | 2020-05-21 |
Publishing country | Germany |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 121471-8 |
ISSN | 1432-1912 ; 0028-1298 |
ISSN (online) | 1432-1912 |
ISSN | 0028-1298 |
DOI | 10.1007/s00210-020-01906-1 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ud II Zs.5: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.